#ACR22 #ICYMI

#YIR

https://twitter.com/PanktiMehta24/status/1591453207523659777

RT @PanktiMehta24@twitter.com

Studies discussed in the #YearinRegiew session at #ACR22

🔸GLORIA trial
🔸ORAL surveillance
🔸MIRROR RCT
🔸Proderm trial
🔸Anti CD 19 CAR T in lupus
🔸 Obinitizumab, iberdomide & litifilimab phase 2 studies in SLE
🔸tocilizumab in polymyalgia rheumatica

#ACRambassador @ACRheum@twitter.com https://twitter.com/rheum_cat/status/1591446357432500225

🐦🔗: https://twitter.com/PanktiMehta24/status/1591453207523659777